Your browser doesn't support javascript.
loading
T cells, B cells, and PD-L1 expression in esophageal and gastric adenocarcinoma before and after neoadjuvant chemotherapy: relationship with histopathological response and survival.
Christina Svensson, Maria; Lindén, Albin; Nygaard, Jakob; Borg, David; Hedner, Charlotta; Nodin, Björn; Leandersson, Karin; Jirström, Karin.
Afiliação
  • Christina Svensson M; Department of Clinical Sciences, Oncology and Therapeutic Pathology, Lund University, Lund, Sweden.
  • Lindén A; Department of Clinical Sciences, Oncology and Therapeutic Pathology, Lund University, Lund, Sweden.
  • Nygaard J; Department of Clinical Sciences, Oncology and Therapeutic Pathology, Lund University, Lund, Sweden.
  • Borg D; Department of Clinical Sciences, Oncology and Therapeutic Pathology, Lund University, Lund, Sweden.
  • Hedner C; Department of Clinical Sciences, Oncology and Therapeutic Pathology, Lund University, Lund, Sweden.
  • Nodin B; Department of Clinical Sciences, Oncology and Therapeutic Pathology, Lund University, Lund, Sweden.
  • Leandersson K; Department of Clinical Sciences Lund, Oncology and Therapeutic Pathology, Lund University, Lund, Sweden.
  • Jirström K; Department of Clinical Sciences, Oncology and Therapeutic Pathology, Lund University, Lund, Sweden.
Oncoimmunology ; 10(1): 1921443, 2021 05 20.
Article em En | MEDLINE | ID: mdl-34104541

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Terapia Neoadjuvante Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Terapia Neoadjuvante Idioma: En Ano de publicação: 2021 Tipo de documento: Article